| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/06/2008 | WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 11/06/2008 | WO2008133272A1 Medicated patch |
| 11/06/2008 | WO2008133157A1 Body-temperature lowering depressant |
| 11/06/2008 | WO2008133102A1 Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion |
| 11/06/2008 | WO2008132756A1 Stable pharmaceutical compositions of ramipril |
| 11/06/2008 | WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer |
| 11/06/2008 | WO2008131506A1 Mucoadhesive granules containing chitosan nano- and/or microspheres and the process of manufacture |
| 11/06/2008 | WO2008115061A3 Dual targeting system |
| 11/06/2008 | WO2008113483A3 Stabilization of vitamin b12 |
| 11/06/2008 | WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 11/06/2008 | WO2008107569A3 Cysteine inclusion complexes and compositions containing same |
| 11/06/2008 | WO2008102349A3 Terbinafine formulation for iontophoresis |
| 11/06/2008 | WO2008100230A8 Membrane(s) and uses thereof |
| 11/06/2008 | WO2008099068A3 Liquid anhydrous composition to be incorporated into the drinking water of cattle |
| 11/06/2008 | WO2008086176A3 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| 11/06/2008 | WO2008073558A3 Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
| 11/06/2008 | WO2008070538A3 Micellar nanoparticles comprising botulinum toxin |
| 11/06/2008 | WO2008055148A3 Semi-solid formulations of phospholipase enzyme inhibitors |
| 11/06/2008 | WO2008052490A3 Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 11/06/2008 | WO2008033924A3 Methods and compositions for targeted delivery of therapeutic agents |
| 11/06/2008 | WO2005003775A9 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 11/06/2008 | US20080275432 Photodynamic foam composition and sclerosis treatment |
| 11/06/2008 | US20080275141 quaternary ammonium compounds, conjugated to polymers, used as microbiocides |
| 11/06/2008 | US20080275140 Hydrolyzing gelatin by contacting a gelatine with one or more proteolytic enzyme having endopeptidase activity and contacting the product with one or more proteolytic enzymes having exopeptidase activity; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 11/06/2008 | US20080275139 Cyclodextrin-Containing Polymers and Uses Thereof |
| 11/06/2008 | US20080275138 Liquid Dispersion Polymer Compositions, Their Preparation And Their Use |
| 11/06/2008 | US20080275077 Pharmaceutical formulations comprising an immune response modifier |
| 11/06/2008 | US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 11/06/2008 | US20080275030 Methods and Compositions for the Delivery of a Therapeutic Agent |
| 11/06/2008 | US20080275020 Pharmaceutical formulation |
| 11/06/2008 | US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders |
| 11/06/2008 | US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders |
| 11/06/2008 | US20080275007 Charged phospholipid compositions and methods for their use |
| 11/06/2008 | US20080275001 Enhanced bioavailability, absorption; using fartty acid, or salt thereof, or fatty ester; sustained release; drug is anticaogulant |
| 11/06/2008 | US20080274986 Drug delivery system for accurate fluid dosing onto ingestible medium followed by vehicle evaporation; simplifies manufacturing and distribution; strength variability |
| 11/06/2008 | US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
| 11/06/2008 | US20080274953 Method of Preparing a Protein Aggregate and a Pharmaceutical Preparation |
| 11/06/2008 | US20080274948 Conjugates of Hydroxyalkyl Starch and G-Csf |
| 11/06/2008 | US20080274201 Coating microcapsule with a photoinitiator, placingin an aqueous macromer solution, exposing to light radiation, polymerization; forming a microcapsule containing at least one cell; macromers are polymerized using a photoinitiator dye; suspension or interfacial polymerization |
| 11/06/2008 | US20080274199 Monodisperse particles having homogeneously dispersed active material; biocompatible, biodegradable |
| 11/06/2008 | US20080274198 Alternating layers of high and low refactive index metal oxides; appealing multicolor appearance; light and moisture protection; shelf life |
| 11/06/2008 | US20080274197 Lyophilized formulation |
| 11/06/2008 | US20080274187 Hard capsule composition and method of use |
| 11/06/2008 | US20080274177 Monolithic coating comprising aqueous dispersion of neutral acrylic ester copolymer without any functional groups and polyglycol; short curing times; shelf life |
| 11/06/2008 | US20080274176 Pharmaceutical Lipid Compositions |
| 11/06/2008 | US20080274168 Transdermal delivery device disposal system |
| 11/06/2008 | US20080274167 Impermeable backing layer, an active substance layer of sufentanyl and a polymer mixture with microreservoirs dispersed, an active substance dissolved in the microreservoirs |
| 11/06/2008 | US20080274164 Atrium Patch |
| 11/06/2008 | US20080274163 Nose and throat anti-influenza solution and method of use |
| 11/06/2008 | US20080274158 biodegradable hydrogel FGF-beta mimetic; PEG-dihydrazide crosslinking agent for a desamino-tyrosyl-tyrosine dipeptide or polypeptides thereof; implantable resorbable medical device; wound healing; the water soluble polymer can also be polysaccharide, polyvinyl alcohol or poly(N-methyl pyrrolidone) |
| 11/06/2008 | US20080274153 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274128 Heat shock protein-based vaccines and immunotherapies |
| 11/06/2008 | US20080274116 Lipids, Lipid Complexes and Use Thereof |
| 11/06/2008 | US20080274050 Labelled Adrenomedullin Derivatives and Their Use for Imaging and Therapy |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | CA2685522A1 High viscosity macromolecular compositions for treating ocular conditions |
| 11/06/2008 | CA2685362A1 Compositions and methods for transmucosal delivery of domperidone |
| 11/06/2008 | CA2685350A1 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 11/06/2008 | CA2685341A1 Macrophage transfection method |
| 11/06/2008 | CA2685331A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 11/06/2008 | CA2685285A1 Methods of reducing nephrotoxicity in subjects administered with nucleoside phosphonates |
| 11/06/2008 | CA2685269A1 Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 11/06/2008 | CA2685264A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
| 11/06/2008 | CA2685261A1 Pharmaceutical excipient complex |
| 11/06/2008 | CA2685184A1 Solid dosage forms |
| 11/06/2008 | CA2685131A1 Stable solid preparation containing 4,5-epoxymorphinan derivative |
| 11/06/2008 | CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 11/05/2008 | EP1988167A2 Inhibiting peptides |
| 11/05/2008 | EP1988108A1 Temperature and pH-sensitive block copolymer having having excellent gel strength, method of preparing the same, and drug delivery system using the same |
| 11/05/2008 | EP1987844A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 11/05/2008 | EP1987843A2 Method for solubilising peptide mixtures |
| 11/05/2008 | EP1987832A1 Sustained-release tablet composition of pramipexole |
| 11/05/2008 | EP1987830A1 Stabilized pharmaceutical composition |
| 11/05/2008 | EP1987825A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 11/05/2008 | EP1987823A1 Condensation aerosol containing zaleplon for inhalation |
| 11/05/2008 | EP1987138A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 11/05/2008 | EP1986700A2 The staudinger reaction in imaging and therapy and kits for use in imaging and therapy |
| 11/05/2008 | EP1986696A2 Method for production of a transformed cell |
| 11/05/2008 | EP1986695A2 Segmented degradable polymers and conjugates made therefrom |
| 11/05/2008 | EP1986694A1 Coupling of polypeptides at the c-terminus |
| 11/05/2008 | EP1986693A1 A base forming drug-layered silicate hybrid containing basic polymer and its synthesis method |
| 11/05/2008 | EP1986692A2 Methods for regulating gelation of polysaccharide solutions and uses thereof |
| 11/05/2008 | EP1986678A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 11/05/2008 | EP1986640A1 Bladder cancer treatment by using e09 and propylene glycol |
| 11/05/2008 | EP1986612A2 Stabilized compositions of proteins having a free thiol moiety |
| 11/05/2008 | EP1986611A2 Repeat sequence protein polymer nanoparticles optionally containing active agents and their preparation |
| 11/05/2008 | EP1986606A2 Phenylephrine-containing liquid formulations |
| 11/05/2008 | EP1986605A2 Apparatus and formulations for suprachoroidal drug delivery |
| 11/05/2008 | EP1986604A1 Aerosol and use thereof |
| 11/05/2008 | EP1824516A4 Glycan analysis using deuterated glucose |
| 11/05/2008 | EP1551390A4 Levamisole, avermectins or similar in pyrrolidone solvent |
| 11/05/2008 | EP1496859B1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 11/05/2008 | EP1465876B1 Long chain fatty alcohol substituents in antineoplastic agents |
| 11/05/2008 | EP1355634B1 Sn-38 lipid complexes and methods of use |
| 11/05/2008 | EP1345630B1 Stabilised radiopharmaceutical compositions |
| 11/05/2008 | EP1303278B1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 11/05/2008 | EP1150712B1 Human papilloma virus vaccine formulations |
| 11/05/2008 | EP0927196B1 Polymers containing polysaccharides such as alginates or modified alginates |
| 11/05/2008 | CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response |